Colistimethate Sodium for Injection 1 MIU.
Swiss Group is in service to medical profession since early fifties. Incorporated as pharmaceutical products distribution & trading house, later on the company expanded in 1987, to become well reputed manufacturer and exporter of pharmaceutical formulations.
Swiss Group is currently having multi locational facilities for manufacturing various finished drug formulations. Our product basket includes Oral solid dosage, Parenteral preparations, Lyophilized parenterals, Liquid formulations and semi solids.
The facilities are built according to current guidelines of WHO GMP, and accreditations with ISO 9001:2008 series standards.With strong network presence in more than 45 countries we are committed to provide quality medicines and better health care.
Our plants carry multiple approvals from various countries across the globe.
We also are proud to announce that our upcoming facility for dedicated sterile dry powder will be ready in January 2013 and is greenfield project spread across in 15,000 square meters and built according to current guidelines of USFDA, MHRA and EU GMP requirements.
The company has dedicated research and development department well equipped with the latest equipments and supported by a large pool, of scientists who continuously work towards new pharma products.
Swiss, where we believe that life is precious and thus we strive to make new “Innovative formulation for better and healthier tomorrow”.
Drug development in today’s market can be challenging. Issues such as poor drug solubility, bioavailability, and limited API are becoming common place…
Swiss offers comprehensive contract pharmaceutical manufacturing services. With full development & manufacturing service in India..
Swiss has a diverse range of Nutraceuticals items to offer from. With in-house capacity right from development to commercial production we can offer…